Phase 2 Randomized Study of Carboplatin/Paclitaxel With or Without CS-7017 in Chemotherapy-Naïve Subjects With Metastatic Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Efatutazone (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 11 Apr 2012 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 04 Apr 2012 Results presented at the 103rd Annual Meeting of the American Association for Cancer Research.
- 06 Sep 2011 Planned End Date changed from 1 Aug 2011 to 1 May 2012 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History